Exclusive-Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the reimbursement available from private employers and insurers, according to an analysis shared with Reuters.
Weight-loss drug Wegovy launched in China
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.
Novo’s Wegovy Launched in China at a Fraction of US Price
Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine for about $193.27 for a one-month supply.
Weight loss drugs Ozempic and Wegovy may also curb alcohol addiction, study says
A study published Wednesday suggests a surprising side effect of GLP-1 drugs such as Ozempic: they can be effective at curbing alcohol abuse.
The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help unemployed people re-enter the workforce and ultimately save money on health care.
FDA adds new warning to weight loss drugs including Wegovy
The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under anesthesia.
Weight-loss drugs replacing some surgeries, but doctors say they're 'not a miracle drug'
Researchers looked at the health records of 17 million Americans with obesity and determined that between 2022 and 2023, rates of bariatric surgeries dropped by 25%, while prescriptions for weight-loss drugs more than doubled.
8 health issues drugs like Wegovy may treat besides weight loss
Not only is Wegovy extremely effective (people lose about 15% of their body weight in a year), it also appears to have many benefits beyond just weight loss.
Novo Nordisk launches obesity drug Wegovy in China
Novo Nordisk said on Monday it has launched its popular obesity drug Wegovy in China, the world's second-largest pharmaceuticals market. A spokesperson for the Danish drugmaker confirmed the news to Reuters after it was first reported by China-based financial media outlet Yicai.
Novo Nordisk reportedly launches Wegovy in China
Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly (LLY). Read more here.
Diabetes and weight loss drugs shown to reduce alcohol-related hospitalizations, study finds
Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...
Should You Skip Your Weight-Loss Injectable to Enjoy Holiday Dinner? Here’s What an Expert Says
Skipping your dose to over-indulge could leave you “excusing yourself from the table in a hurry,” an expert tells PEOPLE.
Benzinga.com12h
Novo Nordisk To Offer Wegovy In China At Fraction Of USA Cost
Wegovy's approval by China's NMPA targets individuals with a BMI of 30+ with related health issues; initial supply will be ...
Mounjaro and Wegovy fact and fiction as experts reveal six things you must know about weight-loss jabs
Two in three adults in England are overweight or obese - and 26 per cent of us have learned all we know about treatments like ...
Wegovy diet plan: What foods to eat and avoid while taking semaglutide
Ro details dietary choices that may help Wegovy's capacity to regulate appetite and foster a healthier weight as well as ...
Healthline6d
Ozempic and Wegovy May Provide Strong Relief from Osteoarthritis Knee Pain
Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.